HOME > ARCHIVE
ARCHIVE
- Politicians' Leadership Essential to Solve Industry Problems: Dr Aoki
October 30, 2006
- JACDS Probes Causes of Sales of Prescription Drugs without Prescription
October 23, 2006
- 2006 Symposium of APEC Network on Pharma Regulatory Science Held in Tokyo
October 23, 2006
- Young Patients More Likely to Be Given New Anti-Psychotics
October 23, 2006
- PFSB Plans Radical Review of PMDA to Speed Drug Approval
October 23, 2006
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
October 23, 2006
- REGULATORY NEWS IN BRIEF -1-
October 23, 2006
- SEMINAR
October 23, 2006
- Tohoku Univ. Researchers Apply for Patent for Vascular Function Monitoring System
October 23, 2006
- SELF-MEDICATION NEWS IN BRIEF
October 23, 2006
- JPA to Launch Data Sheet Database in Early December
October 23, 2006
- SURVEY 2 articles
October 23, 2006
- Shionogi, Hokkaido Univ. Jointly Create Drug Discovery Center
October 23, 2006
- Baxter Announces Results of PI/II Clinical Trial of Cell-Based H5N1 Vaccine
October 23, 2006
- Pulmicort Respules to Popularize Inhalant Steroids in Japan: AstraZeneca
October 23, 2006
- REGULATORY NEWS IN BRIEF -2-
October 23, 2006
- Taiho: Sales Up 2.0%, Strong Growth of TS-1, Global Business Props Up Overall Performance
October 23, 2006
- New Mechanism Leading to Development of Anticancer Drugs Discovered by AIST Researchers
October 23, 2006
- Hisamitsu: Sales Up 9.9%, Net Profits Up 10.3%
October 23, 2006
- Understanding of Public Indispensable to Utilize PGx: Prof. Tsuya
October 23, 2006
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
